U.S. Food Manufacturers: Compare Allergen Tests and Lab Proposals

For U.S. food manufacturers, an allergen-testing quote is comparable only when it names the target, food matrix, method, sampling plan and reporting limits. ELISA and PCR measure different kinds of evidence; select a proposal for the decision it can support rather than treating the methods as interchangeable.[1][3]

Define a food-product testing commission

This guide concerns submitted foods, ingredients and production-environment samples. Patient blood or skin tests are different services. Write a short commission naming the product, suspected allergen source, processing state, production stage and business question.

• Product investigation: Is a specified target detectable in the submitted material?
• Cleaning verification: What evidence is needed from agreed equipment locations after cleaning?
• Supplier or process review: Which ingredient, lot, line or change is being investigated?
• Label or release review: Who will interpret the results alongside formulation, sampling and production records?

For FDA-regulated foods, the major allergen sources are milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame.[1] Name the precise target instead of ordering a vaguely defined “allergen panel.” Confirm product jurisdiction and applicable controls with the appropriate technical adviser; requirements depend on the product and operation.[2]

ELISA versus PCR: what the methods actually compare

FDA describes ELISA as antibody-based testing and identifies PCR as a DNA-based method.[1] Eurofins’ technical guidance explains that ELISA assays target particular food proteins or protein groups, while PCR can provide source-specific detection where a suitable protein assay is unavailable or unsuitable.[3]

• What is measured? — ELISA proposal: A named protein target detected through an antibody assay.[1][3]; PCR proposal: A specified DNA target associated with the food source.[1][3]
• What must match the commission? — ELISA proposal: The protein target, food matrix, extraction and processing state.[3]; PCR proposal: The source target, submitted matrix and intended interpretation of the DNA result.[3]
• What difference matters to the buyer? — ELISA proposal: A kit targeting one protein does not necessarily answer a question about another protein from the same food.[3]; PCR proposal: Source detection must be distinguished from a report that measures allergenic protein; ask the laboratory what conclusion its assay supports.[1][3]
• When is extra review needed? — ELISA proposal: When heating, fermentation or the matrix could affect the kit’s response.[3]; PCR proposal: When PCR is proposed as an alternative: request product-specific suitability evidence rather than assuming DNA testing resolves every limitation.[3]
• What must the quote deliver? — ELISA proposal: The named assay, its applicable analytical limits, units and interpretation.; PCR proposal: The named target, qualitative or quantitative reporting, applicable limits and interpretation.

A practical example is milk testing: Eurofins notes that an ELISA directed at casein does not also detect beta-lactoglobulin.[3] Ask which target the kit measures and why that target answers the product question. Do not infer coverage of all milk-related proteins from the word “milk.”

Processing also matters. Eurofins describes potential ELISA detection problems after protein changes caused by heat or fermentation and says kit selection must fit the matrix.[3] This is a reason to request evidence for the actual processed product, not a blanket rule that PCR is better for cooked foods.

There is no method winner for every commission. Require each laboratory to explain the target-to-result relationship and support its proposed method with relevant validation or verification information.

Compare laboratory proposals using one specification

Give bidders the same finished-product description, formulation information, processing conditions, package and intended use. Ask them to return a proposal that addresses the following items. These are buyer-requested comparison fields, not a universal legal checklist.

• Method identity: Assay name, target, method version and any relevant recognized method designation.
• Matrix suitability: Evidence from the same or a justified comparable matrix, including extraction and known interference.
• Competence: The testing site’s accreditation certificate and applicable scope; verify whether the proposed work falls inside that scope.
• Subcontracting: The site performing each test and responsibility for result review.
• Exceptions: How inadequate recovery, an invalid run or an inconclusive result will be investigated and reported.
• Deliverable: An example report showing target, method, sample identity, units, limits and qualifications.

SGS’s 2011 leaflet is historical background describing product-dependent selection between ELISA and PCR.[4] It does not verify a particular U.S. site’s present accreditation, method scope, capacity or quotation. Confirm those details for the laboratory actually receiving the work.

Agree sampling responsibilities before sending material

Separate the analytical method from the sampling design. The purchase order should identify what the submitted material represents and who is responsible for that design.

• Population: The named lot, production run, ingredient delivery, line or cleaning event.
• Selection: Proposed sample count, collection points, timing and selection rationale.
• Separate or combined samples: Whether increments remain individual or are composited, and what the combined result will represent.
• Custody: Identifiers, collector, date, production conditions, shipping requirements and retained material.
• Deviations: Handling of insufficient, damaged, mislabeled or temperature-affected submissions.

Do not invent one sample count for all products or copy a supplier’s environmental protocol into a finished-food study. Have the qualified laboratory and the manufacturer’s technical lead agree a plan for the actual purpose.

FDA’s food-business guidance describes monitoring and records for facilities subject to preventive-control requirements.[2] A commissioned sample result should therefore be considered alongside applicable production controls and records, rather than being used as a substitute for them.

Make analytical limits and nondetects comparable

Ask each laboratory to define its detection limit, quantitation limit and reporting limit separately, with units and the target and matrix to which each applies. Record whether the result is qualitative or quantitative. Two quotations are not comparable merely because both use “low level” or “ppm.”

Request example wording for detected, not detected, below the reporting limit, estimated, inconclusive and invalid results. Ask what happens when the agreed analytical conditions are not met and whether repeat extraction, dilution, another method or confirmation is required.

FDA states that it has not established a threshold level for allergens on its Food Allergies page.[1] A laboratory’s reporting limit is an analytical boundary, not a blanket consumer-safety threshold. A nondetect should not be presented as proof that every unit, the entire lot or future production is allergen-free.

Put the intended decision and interpretation responsibility in the specification. Identify whether the laboratory will supply data only or also assess results against an agreed criterion. Ask the qualified technical adviser to determine which findings support the specific label or release decision; do not invent a universal pass/fail number.

Keep testing separate from labeling approval

FDA’s January 2025 Edition 5 guidance addresses allergen-labeling questions and explains the distinction between guidance recommendations and cited statutory or regulatory requirements.[5] Confirm the current document and product applicability when making a labeling decision. The laboratory report alone does not assign responsibility for the label or establish a general approval for the business.

For an ingredient intentionally used in the formula, assess formulation and labeling records alongside any test result. For suspected cross-contact, document the investigation, sampling basis and applicable production controls. This article offers procurement questions, not an individualized regulatory determination.

Compare the complete cost and report package

Request project quotations instead of importing consumer allergy-test prices or a foreign laboratory’s tariff into a U.S. food-product commission. Itemize:

• Sample preparation, extraction and each named target or assay.
• Separate samples versus compositing and any minimum order.
• Rush work, confirmation, repeat extraction, retesting and alternative methods.
• Shipping, sample storage, retained material and disposal.
• Data interpretation, consultation, report amendments and raw-data access.
• Cancellation, refunds and authorization for additional paid work.

Define when turnaround begins, whether the advertised time includes confirmation and interpretation, and the consequences of rejected samples. No price or routine turnaround is assumed here for a particular U.S. laboratory.

The accepted report should identify the submitted material, testing site, target, method, results, units, applicable limits and qualifications. Agree the format, authorized signatory, delivery date and amendment process before ordering.

Choose the proposal that answers the production question

1. Fix the product, target and intended decision.
2. Choose the method only after reviewing matrix suitability and what it measures.
3. Verify the performing site’s scope and any subcontracting.
4. Approve the sampling design and custody responsibilities.
5. Agree analytical limits, interpretation, report contents and complete charges.

A stronger proposal makes those commitments explicit and identifies what remains unresolved. It does not need to claim universal method superiority, guarantee absence in untested production or treat one result as a substitute for food-safety and labeling responsibilities.

References

1. FDA — Food Allergies: Major Allergens, Controls and Testing (fda.gov)
2. FDA — How to Start a Food Business (fda.gov)
3. Eurofins — Food Allergen Environmental Monitoring Guide, Technical Background (eurofins.com)
4. SGS — Food Allergen Testing, 2011 Technical Background (sgs.com)
5. FDA — Questions and Answers Regarding Food Allergen Labeling, Edition 5, January 2025 (fda.gov)